Cargando…

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer

Response evaluation at regular intervals is indicated for treatment of metastatic breast cancer (MBC). FDG-PET/CT has the potential to monitor treatment response accurately. Our purpose was to: (a) compare the interrater agreement and reliability of the semi-quantitative PERCIST criteria to qualitat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sørensen, Jonas S., Vilstrup, Mie H., Holm, Jorun, Vogsen, Marianne, Bülow, Jakob L., Ljungstrøm, Lasse, Braad, Poul-Erik, Gerke, Oke, Hildebrandt, Malene G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759893/ https://www.ncbi.nlm.nih.gov/pubmed/33255442 http://dx.doi.org/10.3390/diagnostics10121001

Ejemplares similares

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
por: Vogsen, Marianne, et al.
Publicado: (2021)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019)

Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer
por: Holm, Jorun, et al.
Publicado: (2020)

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2021)

Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

Prognostic Value of Dual-Time-Point (18)F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2020)

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
por: Helland, Fredrik, et al.
Publicado: (2019)

Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
por: Vogsen, Marianne, et al.
Publicado: (2021)

How to assess intra- and inter-observer agreement with quantitative PET using variance component analysis: a proposal for standardisation
por: Gerke, Oke, et al.
Publicado: (2016)

2-[(18)F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2023)

Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
por: Gerke, Oke, et al.
Publicado: (2017)

A prospective study on dual time (18)F-FDG-PET/CT in high-risk prostate cancer patients
por: Mortensen, Mike Allan, et al.
Publicado: (2018)

Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

A randomised trial of [(18)F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol
por: Buch‐Olsen, Karen Middelbo, et al.
Publicado: (2023)

The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [(18)F]FDG-PET/CT and CE-CT
por: Gram-Nielsen, Rosa, et al.
Publicado: (2023)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

Introduction to interrater agreement for nominal data
por: Popping, Roel
Publicado: (2019)

Interrater and intrarater agreement on heart murmurs
por: Andersen, Stian, et al.
Publicado: (2023)

Low-Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2020)

Perspective of Patients With Metastatic Breast Cancer on Electronic Access to Scan Results: Mixed Methods Study
por: Baun, Christina, et al.
Publicado: (2020)

Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
por: Hansen, Jeanette Ansholm, et al.
Publicado: (2021)

An Overview of Interrater Agreement on Likert Scales for Researchers and Practitioners
por: O'Neill, Thomas A.
Publicado: (2017)

Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis
por: Aarstad, Else Marie, et al.
Publicado: (2019)

Assessing Agreement When Agreement Is Hard to Assess—The Agatston Score for Coronary Calcification
por: Andersen, Kristoffer Papsø, et al.
Publicado: (2022)

PET/CT without capacity limitations: a Danish experience from a European perspective
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2011)

Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?
por: Rendl, Gundula, et al.
Publicado: (2022)

Chest Radiographs for Pediatric TB Diagnosis: Interrater Agreement and Utility
por: Kaguthi, G., et al.
Publicado: (2014)

Relationships between Contextual and Task Performance and Interrater Agreement: Are There Any?
por: Díaz-Vilela, Luis F., et al.
Publicado: (2015)

Prospective evaluation of interrater agreement between EEG technologists and neurophysiologists
por: Beuchat, Isabelle, et al.
Publicado: (2021)

Interrater agreement in classifying infections during extracorporeal membrane oxygenation
por: Verkerk, Karlijn, et al.
Publicado: (2023)

Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using (18)F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Interrater Agreement of an Arthroscopic Anterior Cruciate Ligament Tear Classification System
por: Vega, José F., et al.
Publicado: (2020)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

Reporting Standards for a Bland–Altman Agreement Analysis: A Review of Methodological Reviews
por: Gerke, Oke
Publicado: (2020)

2-[18F]FDG-PET/CT in Cancer of Unknown Primary Tumor—A Retrospective Register-Based Cohort Study
por: Rimer, Heidi, et al.
Publicado: (2023)

Nonparametric Limits of Agreement in Method Comparison Studies: A Simulation Study on Extreme Quantile Estimation
por: Gerke, Oke
Publicado: (2020)

Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2020)

Interrater agreement of the HEART score history component: A chart review study
por: Pawlukiewicz, Alec J., et al.
Publicado: (2022)

Human‐to‐AI Interrater Agreement for Lung Ultrasound Scoring in COVID‐19 Patients
por: Fatima, Noreen, et al.
Publicado: (2022)

Intra- and Interrater Agreement of Face Esthetic Analysis in 3D Face Images
por: Park, Minsoo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_855qn8iklojb53jaknbt965uhb